Annual report
4088.TEDINET S100OIFT
Period2021-04-01 → 2022-03-31
Filed2022-06-28
StandardIFRS
ConsolidatedYes
Data checks21 of 22 passed
Amended by S100YTH5 (2026-07-31).
Key figures · 187
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥888.7bn | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥806.6bn | 2020-04-01 → 2021-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥814.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥809.1bn | 2019-04-01 → 2020-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥801.5bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥742.3bn | 2018-04-01 → 2019-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥753.6bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥65.2bn | 2021-04-01 → 2022-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥51.2bn | 2020-04-01 → 2021-03-31 | Cons. | Operating profit loss IFRS |
| Ordinary income | ¥45.2bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥47.0bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥44.7bn | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥64.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥49.7bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥49.8bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥42.1bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥43.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥27.4bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥16.7bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥30.4bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥26.5bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥28.8bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥25.2bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥46.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥30.4bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥33.5bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥30.1bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Total assets | ¥1.02T | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥926.8bn | at 2021-03-31 | Cons. | Assets IFRS |
| Total assets | ¥889.2bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥899.7bn | at 2020-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥783.0bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥785.9bn | at 2019-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥693.1bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥694.9bn | at 2018-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥602.2bn | at 2022-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥554.4bn | at 2021-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥419.9bn | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥372.4bn | at 2021-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥351.8bn | at 2020-03-31d | Cons. | Equity IFRS |
| Net assets / equity | ¥363.8bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥308.7bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥294.6bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Equity (owners) | ¥395.1bn | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥357.8bn | at 2021-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥332.0bn | at 2020-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥278.1bn | at 2019-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥263.6bn | at 2018-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥59.6bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥46.0bn | at 2021-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥41.9bn | at 2020-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥41.4bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥31.5bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥32.1bn | at 2019-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥22.4bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥23.3bn | at 2018-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥71.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥76.6bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥40.0bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥43.8bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥56.7bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥61.2bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥47.8bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥53.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥52.7bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥113.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥115.6bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥88.8bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥91.6bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥61.6bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥6.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥20.9bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥82.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥81.0bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥40.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥39.0bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥4.5bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥191.06 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥120.98 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥81.05 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥147.43 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥135.34 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥147.33 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥128.95 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥190.86 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥120.84 | 2020-04-01 → 2021-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥80.93 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥147.2 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥135.09 | 2018-04-01 → 2019-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥147.06 | 2018-04-01 → 2019-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥128.72 | 2017-04-01 → 2018-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥1,744.42 | at 2022-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,584.86 | at 2021-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,503.42 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,460 | at 2020-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,487.58 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,420.37 | at 2019-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,422.6 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,349.1 | at 2018-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 38.7% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 38.6% | at 2021-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 38.4% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.9% | at 2020-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 37.2% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.4% | at 2019-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 40.1% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.9% | at 2018-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 11.5% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 7.9% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 5.3% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.0% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 9.3% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.6% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 9.4% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 19,299 | at 2022-03-31 | Cons. | Number of employees |
| Revenue | ¥141.8bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥120.7bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥130.8bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥177.4bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥167.8bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥4.7bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | −¥6.6bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥14.4bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥8.9bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥10.8bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥15.8bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥15.5bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥12.3bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥8.8bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥12.9bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥11.6bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | −¥401m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥12.9bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥11.9bn | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥529.4bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥503.4bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥487.2bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥424.9bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥376.7bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥320.2bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥287.3bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥209.2bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥216.1bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥211.0bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥170.8bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥168.4bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥18.6bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥13.5bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥57.26 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥51.49 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.95 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥66.1 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.73 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥57.2 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥51.43 | 2020-04-01 → 2021-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥65.98 | 2018-04-01 → 2019-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥60.62 | 2017-04-01 → 2018-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥56 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥44 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥44 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥38 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥922.25 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥955.98 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥926.42 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥870.14 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥859.95 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 39.5% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.9% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.1% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.6% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.1% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.5% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -0.2% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 229,755,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 229,755,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 229,755,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 198,705,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 198,705,000 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 666 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 853 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 909 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 856 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 1,007 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 133
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2021-04-01 → 2022-03-31 | ¥6.6bn |
| Otherother segments | employees | at 2022-03-31 | 2579 pure |
| Otherother segments | revenue | 2021-04-01 → 2022-03-31 | ¥157.2bn |
| Otherother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥154.1bn |
| Otherother segments | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥3.1bn |
| Otherother segments | segment assets | at 2022-03-31 | ¥188.7bn |
| Otherother segments | segment profit | 2021-04-01 → 2022-03-31 | ¥10.1bn |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥37.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥37.1bn |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥123.6bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | ¥677m |
| Agriculture And Food Productsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥4.8bn |
| Agriculture And Food Productsreportable segment | employees | at 2022-03-31 | 3346 pure |
| Agriculture And Food Productsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥140.2bn |
| Agriculture And Food Productsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥139.5bn |
| Agriculture And Food Productsreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥709m |
| Agriculture And Food Productsreportable segment | segment assets | at 2022-03-31 | ¥91.5bn |
| Agriculture And Food Productsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥5.7bn |
| Chemicalreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥3.9bn |
| Chemicalreportable segment | employees | at 2022-03-31 | 890 pure |
| Chemicalreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥39.5bn |
| Chemicalreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥39.1bn |
| Chemicalreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥351m |
| Chemicalreportable segment | segment assets | at 2022-03-31 | ¥48.6bn |
| Chemicalreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥3.5bn |
| Energyreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥3.5bn |
| Energyreportable segment | employees | at 2022-03-31 | 1052 pure |
| Energyreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥65.1bn |
| Energyreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥61.6bn |
| Energyreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥3.6bn |
| Energyreportable segment | segment assets | at 2022-03-31 | ¥36.6bn |
| Energyreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥4.8bn |
| Industrial Gasreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥12.1bn |
| Industrial Gasreportable segment | employees | at 2022-03-31 | 3004 pure |
| Industrial Gasreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥204.9bn |
| Industrial Gasreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥194.6bn |
| Industrial Gasreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥10.4bn |
| Industrial Gasreportable segment | segment assets | at 2022-03-31 | ¥270.1bn |
| Industrial Gasreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥21.6bn |
| Logisticsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥4.9bn |
| Logisticsreportable segment | employees | at 2022-03-31 | 2658 pure |
| Logisticsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥76.3bn |
| Logisticsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥58.4bn |
| Logisticsreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥17.8bn |
| Logisticsreportable segment | segment assets | at 2022-03-31 | ¥58.1bn |
| Logisticsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥3.1bn |
| Medicalreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥3.0bn |
| Medicalreportable segment | employees | at 2022-03-31 | 4495 pure |
| Medicalreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥195.9bn |
| Medicalreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥195.2bn |
| Medicalreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥747m |
| Medicalreportable segment | segment assets | at 2022-03-31 | ¥137.4bn |
| Medicalreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥11.9bn |
| Seawaterreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥3.8bn |
| Seawaterreportable segment | employees | at 2022-03-31 | 968 pure |
| Seawaterreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥46.7bn |
| Seawaterreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥46.2bn |
| Seawaterreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥519m |
| Seawaterreportable segment | segment assets | at 2022-03-31 | ¥67.4bn |
| Seawaterreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥3.8bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥42.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥925.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥888.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥37.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥898.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥64.5bn |
| Otherother segments | capex | 2020-04-01 → 2021-03-31 | ¥2.7bn |
| Otherother segments | revenue | 2020-04-01 → 2021-03-31 | ¥124.2bn |
| Otherother segments | revenue external | 2020-04-01 → 2021-03-31 | ¥121.3bn |
| Otherother segments | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥2.8bn |
| Otherother segments | segment assets | at 2021-03-31 | ¥148.2bn |
| Otherother segments | segment profit | 2020-04-01 → 2021-03-31 | ¥4.9bn |
| Reconciling Itemsreconciling | capex | 2020-04-01 → 2021-03-31 | ¥2.8bn |
| Reconciling Itemsreconciling | revenue | 2020-04-01 → 2021-03-31 | −¥30.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2020-04-01 → 2021-03-31 | −¥30.5bn |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥119.9bn |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2021-03-31 | −¥1.5bn |
| Agriculture And Food Productsreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥2.6bn |
| Agriculture And Food Productsreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥133.3bn |
| Agriculture And Food Productsreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥132.6bn |
| Agriculture And Food Productsreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥759m |
| Agriculture And Food Productsreportable segment | segment assets | at 2021-03-31 | ¥77.4bn |
| Agriculture And Food Productsreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥4.0bn |
| Chemicalreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥2.6bn |
| Chemicalreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥33.6bn |
| Chemicalreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥33.4bn |
| Chemicalreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥290m |
| Chemicalreportable segment | segment assets | at 2021-03-31 | ¥45.4bn |
| Chemicalreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥2.0bn |
| Energyreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥3.1bn |
| Energyreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥55.7bn |
| Energyreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥53.1bn |
| Energyreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥2.7bn |
| Energyreportable segment | segment assets | at 2021-03-31 | ¥32.1bn |
| Energyreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥4.6bn |
| Industrial Gasreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥17.6bn |
| Industrial Gasreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥192.0bn |
| Industrial Gasreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥185.6bn |
| Industrial Gasreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥6.4bn |
| Industrial Gasreportable segment | segment assets | at 2021-03-31 | ¥250.4bn |
| Industrial Gasreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥20.9bn |
| Logisticsreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥6.7bn |
| Logisticsreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥70.1bn |
| Logisticsreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥53.3bn |
| Logisticsreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥16.8bn |
| Logisticsreportable segment | segment assets | at 2021-03-31 | ¥51.9bn |
| Logisticsreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥2.8bn |
| Medicalreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥5.5bn |
| Medicalreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥186.8bn |
| Medicalreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥186.4bn |
| Medicalreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥357m |
| Medicalreportable segment | segment assets | at 2021-03-31 | ¥132.8bn |
| Medicalreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥10.5bn |
| Seawaterreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥8.4bn |
| Seawaterreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥41.4bn |
| Seawaterreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥41.0bn |
| Seawaterreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥421m |
| Seawaterreportable segment | segment assets | at 2021-03-31 | ¥68.8bn |
| Seawaterreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥3.1bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-04-01 → 2021-03-31 | ¥49.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥837.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥806.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥30.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥807.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥52.7bn |
| Otherother segments | employees | at 2022-03-31 | 28 pure |
| Agriculture And Food Productsreportable segment | employees | at 2022-03-31 | 26 pure |
| Chemicalreportable segment | employees | at 2022-03-31 | 44 pure |
| Energyreportable segment | employees | at 2022-03-31 | 23 pure |
| Industrial Gasreportable segment | employees | at 2022-03-31 | 161 pure |
| Medicalreportable segment | employees | at 2022-03-31 | 66 pure |
| Seawaterreportable segment | employees | at 2022-03-31 | 11 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,683
| Item | Context | Value | Unit |
|---|---|---|---|
| Impairment losses pl IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000MedicalReportableSegmentsMember | 4000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000EnergyReportableSegmentsMember | － | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000AgricultureAndFoodProductsReportableSegmentsMember | 40000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000LogisticsReportableSegmentsMember | － | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000SeawaterReportableSegmentsMember | － | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_OtherReportableSegmentsMember | － | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 45000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_ReconcilingItemsMember | 1000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration | 46000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000IndustrialGasReportableSegmentsMember | 87000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000ChemicalReportableSegmentsMember | － | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000MedicalReportableSegmentsMember | 1021000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000EnergyReportableSegmentsMember | － | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000AgricultureAndFoodProductsReportableSegmentsMember | 43000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000LogisticsReportableSegmentsMember | － | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000SeawaterReportableSegmentsMember | 11000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYearDuration_OtherReportableSegmentsMember | 778000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 1942000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYearDuration_ReconcilingItemsMember | － | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYearDuration | 1942000000 | JPY |
| Investments accounted for using equity method IFRS | CurrentYearInstant_jpcrp030000-asr_E00792-000IndustrialGasReportableSegmentsMember | 1771000000 | JPY |
| Investments accounted for using equity method IFRS | CurrentYearInstant_jpcrp030000-asr_E00792-000ChemicalReportableSegmentsMember | － | JPY |
| Investments accounted for using equity method IFRS | CurrentYearInstant_jpcrp030000-asr_E00792-000MedicalReportableSegmentsMember | 11963000000 | JPY |
| Investments accounted for using equity method IFRS | CurrentYearInstant_jpcrp030000-asr_E00792-000EnergyReportableSegmentsMember | － | JPY |
| Investments accounted for using equity method IFRS | CurrentYearInstant_jpcrp030000-asr_E00792-000AgricultureAndFoodProductsReportableSegmentsMember | 171000000 | JPY |
| Investments accounted for using equity method IFRS | CurrentYearInstant_jpcrp030000-asr_E00792-000LogisticsReportableSegmentsMember | － | JPY |
| Investments accounted for using equity method IFRS | CurrentYearInstant_jpcrp030000-asr_E00792-000SeawaterReportableSegmentsMember | 751000000 | JPY |
| Investments accounted for using equity method IFRS | CurrentYearInstant_OtherReportableSegmentsMember | 15975000000 | JPY |
| Investments accounted for using equity method IFRS | CurrentYearInstant_TotalOfReportableSegmentsAndOthersMember | 30633000000 | JPY |
| Investments accounted for using equity method IFRS | CurrentYearInstant_ReconcilingItemsMember | － | JPY |
| Investments accounted for using equity method IFRS | CurrentYearInstant | 30633000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000IndustrialGasReportableSegmentsMember | 12138000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000ChemicalReportableSegmentsMember | 3858000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000MedicalReportableSegmentsMember | 2958000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000EnergyReportableSegmentsMember | 3478000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000AgricultureAndFoodProductsReportableSegmentsMember | 4838000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000LogisticsReportableSegmentsMember | 4907000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_jpcrp030000-asr_E00792-000SeawaterReportableSegmentsMember | 3792000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_OtherReportableSegmentsMember | 6631000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 42604000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_ReconcilingItemsMember | 2857000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration | 45461000000 | JPY |
| Merchandise and finished goods ca IFRS | Prior1YearInstant | 37245000000 | JPY |
| Merchandise and finished goods ca IFRS | CurrentYearInstant | 41194000000 | JPY |
| Work in process ca IFRS | Prior1YearInstant | 12494000000 | JPY |
| Work in process ca IFRS | CurrentYearInstant | 14113000000 | JPY |
| Raw materials and supplies ca IFRS | Prior1YearInstant | 17940000000 | JPY |
| Raw materials and supplies ca IFRS | CurrentYearInstant | 21096000000 | JPY |
| Inventories ca IFRS | Prior1YearInstant | 67679000000 | JPY |
| Inventories ca IFRS | CurrentYearInstant | 76404000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 22 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | mismatch |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |